INNOVATE (NYSE:VATE – Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.71 EPS for the quarter, topping analysts’ consensus estimates of ($2.18) by $2.89, FiscalAI reports. The company had revenue of $421.60 million for the quarter, compared to analyst estimates of $251.70 million.
Here are the key takeaways from INNOVATE’s conference call:
- Q2 results improved substantially: Revenue rose 74.2% year over year to $421.6 million, Adjusted EBITDA increased to $46.3 million from $15.7 million, and net income attributable to stockholders reached $10.4 million versus a $22 million loss a year ago.
- Infrastructure delivered a record quarter, with DBMG revenue up 77.6% to $414 million and Adjusted EBITDA reaching $48.7 million. Adjusted backlog expanded to $2.7 billion, supported by demand from data centers, technology, healthcare, semiconductors, energy systems, and digital connectivity.
- INNOVATE refinanced Broadcasting with $105 million of financing and agreed to sell CONX a controlling 75% interest, while retaining 25% and an option to increase its stake to 40%. CONX also committed up to $75 million of post-closing equity capital, although closing remains subject to FCC and other regulatory approvals.
- MediBeacon reported continued progress in commercial placements and is engaging with more than 100 healthcare institutions, while pursuing reimbursement and regulatory initiatives. Its Lumitrace marketing authorization application in Europe is targeted for filing in 2027, indicating meaningful commercialization opportunities remain longer term.
- Liquidity and financing remain constraints in parts of the portfolio: consolidated cash declined to $87.8 million from $108.2 million at year-end, total debt rose to $626.4 million, and R2’s revenue fell 31.3% due partly to liquidity-related reductions in unit sales. R2 is seeking additional capital to fund inventory, manufacturing, and commercial expansion.
INNOVATE Stock Performance
NYSE VATE traded up $4.86 during trading hours on Friday, hitting $12.27. 14,230,004 shares of the company traded hands, compared to its average volume of 96,867. The business’s 50-day moving average is $13.45 and its 200-day moving average is $9.79. INNOVATE has a twelve month low of $3.75 and a twelve month high of $21.30.
Institutional Investors Weigh In On INNOVATE
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on VATE shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of INNOVATE in a report on Monday, May 18th. Wall Street Zen upgraded shares of INNOVATE to a “buy” rating in a report on Saturday, May 16th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, INNOVATE currently has a consensus rating of “Sell”.
Get Our Latest Analysis on INNOVATE
INNOVATE Company Profile
INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. The Infrastructure segment provides industrial construction, structural steel, and facility maintenance services, such as fabrication and erection of structural steel and heavy steel plate services, and large-diameter water pipes and water storage tanks; fabrication of trusses and girders; and 3-D building information modeling and detailing for commercial, industrial, and infrastructure construction projects, such as buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills, and power plants.
Read More
- Five stocks we like better than INNOVATE
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for INNOVATE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INNOVATE and related companies with MarketBeat.com's FREE daily email newsletter.
